Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02273739 |
Title | Study of Orally Administered AG-221 in Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | Yes |
Sponsors | Agios Pharmaceuticals, Inc. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | FRA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Los Angeles | California | 90095 | United States | Details | ||
Los Angeles | California | 91010 | United States | Details | ||
Miami | Florida | 33136 | United States | Details | ||
Baltimore | Maryland | 21287 | United States | Details | ||
Boston | Massachusetts | 02114 | United States | Details | ||
Omaha | Nebraska | 68198 | United States | Details | ||
New York | New York | 10065 | United States | Details | ||
Cleveland | Ohio | 44195 | United States | Details | ||
Nashville | Tennessee | 37203 | United States | Details | ||
Dallas | Texas | 75390 | United States | Details | ||
Bordeaux | 61283 33076 | France | Details | |||
Villejuif Cedex | 94805 | France | Details |